| Literature DB >> 27160799 |
Daniël H van Raalte1, C Bruce Verchere2.
Abstract
Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.Entities:
Keywords: Glucagon-like peptide (GLP)-1 receptor agonists; beta-cell exhaustion; beta-cell protection; chronic treatment; insulin secretion
Mesh:
Substances:
Year: 2016 PMID: 27160799 DOI: 10.1016/j.tem.2016.04.009
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015